Julie Milia
75 works · 4,870 citations · h-index 21
Top works
- Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
- Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
- Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
- Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
- Targeting RET in Patients With RET -Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
- Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort
- Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET–Rearranged Lung Cancers
- Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
- Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung
- Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).
- Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
- Characteristics of lung cancer in women: Importance of hormonal and growth factors
- Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
- When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
- Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked
- Perception of Lung Cancer among the General Population and Comparison with Other Cancers
- Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry.
- Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1
- Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication